LeBron shrugs off Trump blast in home debut win for Philadelphia 76ers

Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs

<p>World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol</p><p>Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.</p><p>The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext">can reduce the desire to drink alcohol</a>, which could lead to “fullness and fewer serves” of pints in pubs and bars.</p> <a href="https://www.theguardian.com/business/2026/oct/23/weight-loss-drugs-beer-sales-heineken-british-pubs-wegovy">Continue reading...</a>